Equifax (NYSE:EFX) Given New $185.00 Price Target at BNP Paribas Exane

Equifax (NYSE:EFX) had its price objective decreased by stock analysts at BNP Paribas Exane from $195.00 to $185.00 in a research note issued on Thursday,MarketScreener reports. The brokerage presently has a “neutral” rating on the credit services provider’s stock. BNP Paribas Exane’s target price suggests a potential upside of 18.73% from the company’s previous close.

Several other brokerages have also weighed in on EFX. Needham & Company LLC reissued a “buy” rating and issued a $265.00 price objective on shares of Equifax in a report on Wednesday, April 22nd. Citigroup dropped their price objective on shares of Equifax from $256.00 to $238.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Mizuho began coverage on shares of Equifax in a research report on Thursday, April 16th. They issued an “outperform” rating and a $222.00 price target on the stock. Wells Fargo & Company dropped their price target on shares of Equifax from $230.00 to $220.00 and set an “overweight” rating on the stock in a research note on Thursday. Finally, UBS Group lifted their price objective on shares of Equifax from $212.00 to $215.00 and gave the company a “buy” rating in a research note on Tuesday. Thirteen equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $225.28.

Equifax Stock Performance

Shares of NYSE:EFX traded up $0.97 during mid-day trading on Thursday, reaching $155.81. The company had a trading volume of 192,807 shares, compared to its average volume of 1,768,183. Equifax has a one year low of $152.95 and a one year high of $275.91. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 0.89. The company’s 50-day moving average price is $171.94 and its 200-day moving average price is $191.97. The firm has a market cap of $18.55 billion, a price-to-earnings ratio of 27.43, a PEG ratio of 1.24 and a beta of 1.32.

Equifax (NYSE:EFX) last released its earnings results on Tuesday, April 21st. The credit services provider reported $1.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.69 by $0.17. The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.61 billion. Equifax had a return on equity of 20.41% and a net margin of 11.12%.The business’s revenue for the quarter was up 14.3% on a year-over-year basis. During the same period last year, the business posted $1.53 earnings per share. Equifax has set its Q2 2026 guidance at 2.150-2.250 EPS and its FY 2026 guidance at 8.340-8.740 EPS. As a group, equities research analysts anticipate that Equifax will post 8.57 EPS for the current fiscal year.

Insider Activity

In related news, CEO Mark W. Begor sold 37,791 shares of the company’s stock in a transaction that occurred on Friday, April 24th. The shares were sold at an average price of $172.40, for a total value of $6,515,168.40. Following the transaction, the chief executive officer directly owned 271,730 shares in the company, valued at approximately $46,846,252. This represents a 12.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Chad M. Borton sold 2,455 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $173.89, for a total transaction of $426,899.95. Following the completion of the sale, the executive vice president directly owned 29,518 shares in the company, valued at $5,132,885.02. This represents a 7.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Equifax

A number of large investors have recently added to or reduced their stakes in the company. Cullen Frost Bankers Inc. purchased a new position in shares of Equifax in the 4th quarter worth about $25,000. Ameriflex Group Inc. lifted its position in Equifax by 612.5% in the 4th quarter. Ameriflex Group Inc. now owns 114 shares of the credit services provider’s stock worth $25,000 after buying an additional 98 shares during the last quarter. Kemnay Advisory Services Inc. bought a new stake in Equifax in the 4th quarter worth approximately $26,000. Reflection Asset Management purchased a new stake in Equifax in the fourth quarter worth approximately $26,000. Finally, Caitong International Asset Management Co. Ltd bought a new position in Equifax during the third quarter valued at approximately $34,000. Hedge funds and other institutional investors own 96.20% of the company’s stock.

Equifax Company Profile

Equifax Inc (NYSE: EFX) is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.

The company’s offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.